Literature DB >> 16091485

Distinctive inhibitory mechanisms of age and relative visceral adiposity on growth hormone secretion in pre- and postmenopausal women studied under a hypogonadal clamp.

Johannes D Veldhuis1, Dana Erickson, Kristi Mielke, Leon S Farhy, Daniel M Keenan, Cyril Y Bowers.   

Abstract

BACKGROUND: Aging, body composition, and sex steroids jointly determine GH production. However, the actions of any given factor are confounded by the effects of the other two. HYPOTHESIS: Age and abdominal visceral fat (AVF) mass govern GH secretion via individually distinctive mechanisms, which can be unmasked by short-term sex steroid deprivation. DESIGN/
SUBJECTS: In a university setting, healthy pre- and postmenopausal volunteers underwent GnRH agonist-induced down-regulation for 6 wk to deplete ovarian sex steroids. GH secretion was evaluated by frequent blood sampling, saline vs. dual secretagogue infusions, an irregularity statistic, variable waveform deconvolution analysis, and a simplified feedback model. Computerized tomography was used to estimate AVF mass. OUTCOMES/MEASURES: In the sex steroid-deficient milieu, postmenopausal compared with premenopausal women exhibited 1) lower concentrations of IGF-I (P = 0.028) and GH (P < 0.05); 2) reduced pulsatile, but elevated basal, GH secretion (P < 0.05); 3) more irregular GH patterns (P = 0.027); 4) an attenuated GH response to simultaneous GHRH/GH-releasing peptide-2 stimulation (P < 0.01); and 5) more rapid onset of GH release within secretory bursts (P < 0.01). In contrast, AVF negatively forecast GH responses to L-arginine/GH-releasing peptide-2 (r2= 0.45; P < 0.001) and L-arginine/GHRH (r2= 0.57; P = 0.007). From these marked contrasts, model-based analyses predicted distinguishable mechanisms by which aging and AVF alter pulsatile GH production.
CONCLUSION: Under limited confounding by sex steroids, age and body composition modulate GH secretion via highly selective peptidyl pathways in healthy women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091485     DOI: 10.1210/jc.2005-0854

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.

Authors:  Ali Iranmanesh; Cyril Y Bowers; Johannes D Veldhuis
Journal:  Eur J Endocrinol       Date:  2010-03-18       Impact factor: 6.664

2.  Regulation of basal, pulsatile, and entropic (patterned) modes of GH secretion in a putatively low-somatostatin milieu in women.

Authors:  Johannes D Veldhuis; Susan A Hudson; Joy N Bailey; Dana Erickson
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-02       Impact factor: 4.310

3.  Immunological and mass spectrometric assays of SHBG: consistent and inconsistent metabolic associations in healthy men.

Authors:  Johannes D Veldhuis; Olga P Bondar; Roy B Dyer; Sergey A Trushin; Eric W Klee; Ravinder J Singh; George G Klee
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

4.  Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men.

Authors:  Ali Iranmanesh; Donna Lawson; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2012-04-03       Impact factor: 5.958

Review 5.  Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women.

Authors:  Johannes D Veldhuis
Journal:  Ageing Res Rev       Date:  2008-01-05       Impact factor: 10.895

6.  Interleukins 6 and 8 and abdominal fat depots are distinct correlates of lipid moieties in healthy pre- and postmenopausal women.

Authors:  Johannes D Veldhuis; Roy B Dyer; Sergey A Trushin; Olga P Bondar; Ravinder J Singh; George G Klee
Journal:  Endocrine       Date:  2016-07-22       Impact factor: 3.633

7.  Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; Adebordurin M Adeniji; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

8.  Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

9.  GH/GHRH axis in HIV lipodystrophy.

Authors:  Takara L Stanley; Steven K Grinspoon
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

10.  Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.

Authors:  Johannes D Veldhuis; Kristi L Mielke; Mihaela Cosma; Cacia Soares-Welch; Remberto Paulo; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.